Table 6.
Biomarkers | AUROC | 95% CI | P value | Cut-off | Sensitivity | Specificity | PV + | PV − | LR + | LR − |
---|---|---|---|---|---|---|---|---|---|---|
RDW | 0.519 | 0.443–0.596 | < 0.001 | 13.7 | 0.40 | 0.71 | 0.77 | 0.34 | 1.39 | 0.84 |
ESR | 0.764 | 0.701–0.828 | 0.222 | 16.0 | 0.67 | 0.77 | 0.87 | 0.50 | 2.90 | 0.42 |
CRP | 0.814 | 0.760–0.868 | 0.795 | 3.32 | 0.79 | 0.75 | 0.88 | 0.60 | 3.21 | 0.28 |
NLR | 0.683 | 0.611–0.756 | 0.003 | 2.01 | 0.67 | 0.63 | 0.81 | 0.45 | 1.82 | 0.52 |
PLR | 0.643 | 0.570–0.716 | < 0.001 | 132 | 0.70 | 0.56 | 0.79 | 0.44 | 1.59 | 0.54 |
LMR | 0.762 | 0.697–0.826 | 0.282 | 3.59 | 0.77 | 0.73 | 0.87 | 0.58 | 2.82 | 0.31 |
Fibrinogen | 0.806 | 0.751–0.861 | Ref | 3.22 | 0.70 | 0.77 | 0.88 | 0.52 | 3.02 | 0.39 |
DeLong test was used to compare the AUROC between fibrinogen and other biomarkers and estimate P values and fibrinogen was the reference. AUROC area under the receiver operating characteristic curve; CI confidence interval; PV + positive predictive value; PV − negative predictive value; LR + positive likelihood ratio; LR − negative likelihood ratio; RDW red cell distribution width; ESR erythrocyte sedimentation rate; CRP C-reactive protein; NLR neutrophil to lymphocyte ratio; PLR platelet to lymphocyte ratio; LMR lymphocyte to monocyte ratio